ee7a8b68e2ac2291ea6778d2350c0fec *DESCRIPTION
3d3e52e370d740c635b371f1a44fc3f8 *NAMESPACE
666f90d979b191110df1637898cac2c4 *R/active_premium.R
dfad194f4b83acf77d55776ca3f4c5b1 *R/alpha_capm.R
10e3d1cfee54af2c6625b15ec9f42bb0 *R/beta_capm.R
1c45ea19210967a936b7ccceb42d029e *R/funds.R
0ecbc6dc83f90e2a53aae3eef56e8047 *R/information_ratio.R
26b3056b2eb0ff623de94e3dccb99c24 *R/jenson_alpha.R
0fb3b46662a0ed7c5fde9afb0a8dfeab *R/markowitz_model.R
769470be9cbd1d4bb3ee04af13495fdc *R/ratio_sharpe.R
dca7307f8edaf0ea14f7f4b744992785 *R/ratio_sortino.R
de28e8bc01a2d4e980fc8d72073e8873 *R/ratio_treynor.R
26601d03290093757c851a601ffbbf93 *R/returns_annualized.R
d53646baf66d22a91801fbc399176d2b *R/risk_premium.R
aab1c1a80f11a50ecfea86d1df935bb8 *R/semi_deviation.R
e43f7a658b8b8776dce99d2f0edfd8a5 *R/tracking_error.R
401e22d4bdeb12aa3529bf46774d002e *data/funds.rda
2c30a13411e634f5137abcb674fad401 *man/alpha.capm.Rd
b70e5f494b825125186fb31a61b68c4a *man/beta.capm.Rd
7bfd75848c6b22da9005aa98b9450d64 *man/funds.Rd
c8b5395e01fd9e94c28a1cc0fb5e0c56 *man/jenson.alpha.Rd
70d34c8de496f177a7d2624cb350bb26 *man/markowitz.model.Rd
df5d6b4078ba43c4c084535ff76ce67f *man/premium.active.Rd
d0243ef84893611a58b432790cfe0a64 *man/ratio.information.Rd
1397a3f3e2edd8ed0554d6fc2bc082e8 *man/ratio.sharpe.Rd
539b1e81509d4f3a96cf12472d47b8ad *man/ratio.sortino.Rd
4fa30f6c24019ef33dd7ad3247ae2a81 *man/ratio.treynor.Rd
716e9febab0364088f9c5a7b2cd02fa6 *man/returns.cal.Rd
62c33726b043c62c84e91e25847b98d0 *man/risk.premium.Rd
adf994f597ce535bf9e06d1a917fb9a1 *man/semi.deviation.Rd
39f1f825be6c6f1189b0c7889fd9d09c *man/tracking.error.Rd
332173f20d20942c02019350ea4dcadc *tests/spelling.R
